Basel, Switzerland

John Graham Cumming


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by John Graham Cumming in Pharmaceutical Patents

Introduction: John Graham Cumming is a notable inventor based in Basel, Switzerland, recognized for his contributions to pharmaceutical innovation. Holding two patents, he has been instrumental in advancing drug development focused on addressing various inflammatory conditions.

Latest Patents: Cumming's latest patents include significant inventions related to inhibitors of protease-activated receptor-2. The first patent details certain substituted imidazole compounds along with pharmaceutical compositions containing them. These compounds aim to treat a range of conditions such as pain, musculoskeletal inflammation, neuroinflammatory disorders, airway inflammation, itch, dermatitis, colitis, and other related ailments. The compounds described in the patent follow certain structural formulas, where X can be N or CH, and Z and Y can be N or C but both cannot be N simultaneously. The second patent offers similar innovations but focuses on triazole compounds, expanding the potential therapeutic applications for treating similar inflammatory conditions.

Career Highlights: John Graham Cumming works at Heptares Therapeutics Limited, a company dedicated to pioneering drug discovery and development. His role at Heptares Therapeutics places him at the forefront of research aimed at developing new therapeutic agents for complex diseases.

Collaborations: In his innovative journey, Cumming collaborates with talented professionals such as Frank Xinhe Wu and Karl Henrik Edman. These partnerships enhance the research capabilities and broaden the scope of discoveries within the pharmaceutical domain.

Conclusion: John Graham Cumming exemplifies the dedication and ingenuity required in the field of pharmaceutical innovation. His patents on inhibitors of protease-activated receptor-2 reflect a significant step towards developing effective treatments for various inflammatory disorders. Through his work at Heptares Therapeutics and collaborations with esteemed colleagues, Cumming continues to make impactful contributions to medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…